Publications by authors named "Ippei Yoshida"

Claim this Profile
A
A Disease Progression Predictor by Quantitative Assessment of the Hepatic Accumulation on Postablative Iodine-131 Whole-Body Image in Differentiated Thyroid Cancer.
Michihiro Nakayama, Kenta Nomura, Sho Kamieda, Ippei Yoshida, Atsushi Fujiya

Mol Imaging Radionucl Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras.
Akiko Oya, Michihiro Nakayama, Takahiro Uno, Haruka Ueda, Ippei Yoshida

Ann Nucl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A spreading roots sign: Characteristic sign of the preliminary stage of medial meniscus posterior root tear on magnetic resonance imaging.
Ryuichi Nakamura, Akira Okano, Ippei Yoshida, Tomoyuki Shimakawa

J Orthop Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP0586532, a Novel Non-Hydroxamate LpxC Inhibitor: Potentiating Effect on Activity of Meropenem against Carbapenem-Resistant Enterobacteriaceae.
Ippei Yoshida, Iichiro Takata, Kiyoko Fujita, Hajime Takashima, Hiroyuki Sugiyama

Microbiol Spectr· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic target assessment and prediction of clinically effective dosing regimen of TP0586532, a novel non-hydroxamate LpxC inhibitor, using a murine lung infection model.
Kiyoko Fujita, Iichiro Takata, Ippei Yoshida, Yusuke Honma, Hirotoshi Okumura

J Infect Chemother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP0586532, a non-hydroxamate LpxC inhibitor, reduces LPS release and IL-6 production both in vitro and in vivo.
Kiyoko Fujita, Iichiro Takata, Ippei Yoshida, Hajime Takashima, Hiroyuki Sugiyama

J Antibiot (Tokyo)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae.
Kiyoko Fujita, Iichiro Takata, Ippei Yoshida, Hirotoshi Okumura, Katsumasa Otake

J Antibiot (Tokyo)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
Ippei Yoshida, Kaho Arikawa, Yusuke Honma, Shoko Inatani, Mitsukane Yoshinaga

Antimicrob Agents Chemother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent dual inhibitor of wild-type and mutant respiratory syncytial virus fusion proteins through the modulation of atropisomer interconversion properties.
Toru Yamaguchi-Sasaki, Takanori Kawaguchi, Atsushi Okada, Seiken Tokura, Nozomi Tanaka-Yamamoto, Ippei Yoshida

Bioorg Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins.
Toru Yamaguchi-Sasaki, Seiken Tokura, Yuya Ogata, Takanori Kawaguchi, Yutaka Sugaya, Ippei Yoshida

ACS Med Chem Lett· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect on subjective quality of life of occupational therapy based on adjusting the challenge-skill balance: a randomized controlled trial.
Ippei Yoshida, Kazuki Hirao, Ryuji Kobayashi

Clin Rehabil· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of adjusting the challenge-skill balance for occupational therapy: study protocol for a randomised controlled trial.
Ippei Yoshida, Kazuki Hirao, Ryuji Kobayashi

BMJ Open· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusting Challenge-Skill Balance to Improve Quality of Life in Older Adults: A Randomized Controlled Trial.
Ippei Yoshida, Kazuki Hirao, Tetsushi Nonaka

Am J Occup Ther· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro antibacterial activity of α-methoxyimino acylide derivatives against macrolide-resistant pathogens and mutation analysis in 23S rRNA.
Hiroyuki Sugiyama, Ippei Yoshida, Mayumi Ueki, Katsuhiko Tanabe, Akira Manaka

J Antibiot (Tokyo)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis